Drug Shortage Report for 5% DEXTROSE INJECTION, USP
Report ID | 150508 |
Drug Identification Number | 00060348 |
Brand name | 5% DEXTROSE INJECTION, USP |
Common or Proper name | 5% DEXTROSE INJECTION, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50 mL (JB0040) |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-12-06 |
Actual start date | 2021-12-06 |
Estimated end date | 2022-09-16 |
Actual end date | 2022-09-16 |
Shortage status | Resolved |
Updated date | 2022-09-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-02-14 | English | Compare |
v3 | 2021-12-07 | English | Compare |
v2 | 2021-12-06 | French | Compare |
v1 | 2021-12-06 | English | Compare |